Author:
Weigt David,Parrish Cynthia A.,Krueger Julie A.,Oleykowski Catherine A.,Rendina Alan R.,Hopf Carsten
Funder
BMBF
Deutsche Forschungsgemeinschaft
Subject
Clinical Biochemistry,Drug Discovery,Pharmacology,Molecular Biology,Molecular Medicine,Biochemistry
Reference45 articles.
1. Adams, N.D. (2011). Triazolones as fatty acid synthase inhibitors. World Intellectual Property Organization WO2011103546.
2. Fasnall, a selective FASN inhibitor, shows potent anti-tumor activity in the MMTV-Neu model of HER2(+) breast cancer;Alwarawrah;Cell Chem. Biol.,2016
3. Single-cell MALDI-MS as an analytical tool for studying intrapopulation metabolic heterogeneity of unicellular organisms;Amantonico;Anal. Chem.,2010
4. Recent advances in targeting the fatty acid biosynthetic pathway using fatty acid synthase inhibitors;Angeles;Expert Opin. Drug Discov.,2016
5. Integration of an in situ MALDI-based high-throughput screening process: a case study with receptor tyrosine kinase c-MET;Beeman;SLAS Discov.,2017
Cited by
14 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献